Skip to main content

previous disabled Page of 2
and
  1. Article

    Open Access

    Feasibility of risk assessment for breast cancer molecular subtypes

    Few breast cancer risk assessment models account for the risk profiles of different tumor subtypes. This study evaluated whether a subtype-specific approach improves discrimination.

    Anne Marie McCarthy, Sarah Ehsan, Kevin S. Hughes in Breast Cancer Research and Treatment (2024)

  2. No Access

    Article

    Mainstreamed genetic testing of breast cancer patients: experience from a single surgeon’s practice in a large US Academic Center

    This study evaluated the impact of mainstreamed genetic testing (MGT) on the timing and uptake of testing in an academic breast surgeon’s practice. Before September 2019 (pre-MGT phase), a breast surgery pract...

    Teresa S. Chai, Kanhua Yin, Mackenzie Wooters, Kristen M. Shannon in Familial Cancer (2023)

  3. No Access

    Article

    Familial pancreatic cancer: who should be considered for genetic testing?

    Determining how many female patients who underwent breast imaging meet the eligibility criteria for genetic testing for familial pancreatic cancer (FPC).

    Kinyas Kartal, Zoe Guan, Rong Tang in Irish Journal of Medical Science (1971 -) (2022)

  4. No Access

    Article

    Penetrance of male breast cancer susceptibility genes: a systematic review

    Several male breast cancer (MBC) susceptibility genes have been identified, but the MBC risk for individuals with a pathogenic variant in each of these genes (i.e., penetrance) remains unclear. We conducted a ...

    Reem S. Chamseddine, Cathy Wang, Kanhua Yin in Breast Cancer Research and Treatment (2022)

  5. No Access

    Article

    Management and outcomes of men diagnosed with primary breast cancer

    Fewer than 1% of all breast cancers occur in men. As a result, a distinct lack of data exists regarding the management and outcomes in this cohort.

    Andrew E. Johnson, Suzanne B. Coopey in Breast Cancer Research and Treatment (2021)

  6. Article

    Open Access

    Performance of a novel protease-activated fluorescent imaging system for intraoperative detection of residual breast cancer during breast conserving surgery

    Safe breast cancer lumpectomies require microscopically clear margins. Real-time margin assessment options are limited, and 20–40% of lumpectomies have positive margins requiring re-excision. The LUM Imaging S...

    Conor R. Lanahan, Bridget N. Kelly, Michele A. Gadd in Breast Cancer Research and Treatment (2021)

  7. No Access

    Article

    Disease spectrum of gastric cancer susceptibility genes

    Pathogenic variants in germline cancer susceptibility genes can increase the risk of a large number of diseases. Our study aims to assess the disease spectrum of gastric cancer susceptibility genes and to deve...

    Sophia K. McKinley, Preeti Singh, Kanhua Yin, ** Wang, **gan Zhou in Medical Oncology (2021)

  8. No Access

    Article

    Incidental breast carcinoma: incidence, management, and outcomes in 4804 bilateral reduction mammoplasties

    Bilateral reduction mammoplasty is one of the most common plastic surgery procedures performed in the U.S. This study examines the incidence, management, and prognosis of incidental breast cancer identified in...

    Rong Tang, Francisco Acevedo, Conor Lanahan in Breast Cancer Research and Treatment (2019)

  9. No Access

    Article

    Atypical ductal hyperplasia in men with gynecomastia: what is their breast cancer risk?

    Atypical ductal hyperplasia (ADH) significantly increases the risk of breast cancer in women. However, little is known about the implications of ADH in men.

    Suzanne B. Coopey, Kinyas Kartal, Clara Li in Breast Cancer Research and Treatment (2019)

  10. No Access

    Article

    Pathologic findings in reduction mammoplasty specimens: a surrogate for the population prevalence of breast cancer and high-risk lesions

    Mammoplasty removes random samples of breast tissue from asymptomatic women providing a unique method for evaluating background prevalence of breast pathology in normal population. Our goal was to identify the...

    Francisco Acevedo, V. Diego Armengol, Zhengyi Deng in Breast Cancer Research and Treatment (2019)

  11. No Access

    Article

    A Clinical Decision Support Tool to Predict Cancer Risk for Commonly Tested Cancer-Related Germline Mutations

    The rapid drop in the cost of DNA sequencing led to the availability of multi-gene panels, which test 25 or more cancer susceptibility genes for a low cost. Clinicians and genetic counselors need a tool to int...

    Danielle Braun, Jiabei Yang, Molly Griffin in Journal of Genetic Counseling (2018)

  12. No Access

    Chapter

    Breast Cancer Risk Prediction in Women with Atypical Breast Lesions

    Women with atypical breast lesions have a markedly increased risk of develo** breast cancer. The risk of breast cancer in women with lobular carcinoma in situ is seven- to nine-fold that of the general popul...

    Suzanne B. Coopey, Kevin S. Hughes in Atypical Breast Proliferative Lesions and … (2018)

  13. No Access

    Article

    Reassessing risk models for atypical hyperplasia: age may not matter

    The aim of this study was to investigate the influence of age at diagnosis of atypical hyperplasia (“atypia”, ductal [ADH], lobular [ALH], or severe ADH) on the risk of develo** subsequent invasive breast ca...

    Emanuele Mazzola, Suzanne B. Coopey, Molly Griffin in Breast Cancer Research and Treatment (2017)

  14. Article

    Erratum to: Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

    Jessica A. Cintolo-Gonzalez, Danielle Braun in Breast Cancer Research and Treatment (2017)

  15. No Access

    Article

    Breast cancer risk models: a comprehensive overview of existing models, validation, and clinical applications

    Numerous models have been developed to quantify the combined effect of various risk factors to predict either risk of develo** breast cancer, risk of carrying a high-risk germline genetic mutation, specifica...

    Jessica A. Cintolo-Gonzalez, Danielle Braun in Breast Cancer Research and Treatment (2017)

  16. No Access

    Article

    Using machine learning to parse breast pathology reports

    Extracting information from electronic medical record is a time-consuming and expensive process when done manually. Rule-based and machine learning techniques are two approaches to solving this problem. In th...

    Adam Yala, Regina Barzilay, Laura Salama in Breast Cancer Research and Treatment (2017)

  17. No Access

    Chapter

    Risk Assessment for Breast Cancer

    Genetic testing for individuals with familial or hereditary risk for breast cancer is essential to improving prevention and survival. Identifying unaffected BRCA1/2 mutation carriers before they develop breast ca...

    Anvy Nguyen, Jessica Cintolo-Gonzalez in Managing BRCA Mutation Carriers (2017)

  18. Article

    DCIS does not need treatment… really?

    Kevin S. Hughes in Breast Cancer Research and Treatment (2015)

  19. No Access

    Article

    Doing “nothing” for DCIS: a case report

    Margo M. Moskos, Kevin S. Hughes in Breast Cancer Research and Treatment (2015)

  20. No Access

    Article

    False-negative rate of combined mammography and ultrasound for women with palpable breast masses

    Mammography and ultrasound are often used concurrently for patients with palpable breast masses. While mammography has a false-negative rate of approximately 15 %, the addition of breast ultrasound decreases t...

    Carlos H. F. Chan, Suzanne B. Coopey in Breast Cancer Research and Treatment (2015)

previous disabled Page of 2